Takeda Pharmaceutical (TAK) Set to Announce Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) will post its quarterly earnings results before the market opens on Thursday, October 31st. Analysts expect Takeda Pharmaceutical to post earnings of $0.39 per share for the quarter. Takeda Pharmaceutical has set its FY 2024 guidance at 2.770-2.770 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Takeda Pharmaceutical (NYSE:TAK) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.37 by $0.19. The company had revenue of $7.75 billion during the quarter. Takeda Pharmaceutical had a return on equity of 10.11% and a net margin of 6.02%. On average, analysts expect Takeda Pharmaceutical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Takeda Pharmaceutical Price Performance

Shares of TAK opened at $13.59 on Tuesday. The company has a current ratio of 1.26, a quick ratio of 0.74 and a debt-to-equity ratio of 0.65. The company’s fifty day simple moving average is $14.55 and its 200 day simple moving average is $13.78. Takeda Pharmaceutical has a 1-year low of $12.57 and a 1-year high of $15.08. The company has a market cap of $43.24 billion, a price-to-earnings ratio of 25.64, a PEG ratio of 0.26 and a beta of 0.54.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.